| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 5 e, j, o
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF32 (in situ hybridization)
|
|
|
|
Fig 3 EFGHIJKL
Mann N et al. (2021)
|
Xla Wt + prdm15 MO + GFP
NF35/36 (in situ hybridization)
|
|
Galloway-Mowat syndrome 1
|
|
Fig. 10
DeLay BD et al. (2019)
|
Xla Wt + dnmbp MO
NF40-41 (in situ hybridization)
|
|
|
|
Fig. 2 B, i-m
Buisson I et al. (2015)
|
Xla Wt + pax2 MO
NF33/34-35/36 (in situ hybridization)
|
|
|
|
Sup.Fig. S2 A a-k
Buisson I et al. (2015)
|
Xla Wt + pax2 MO3
NF33/34-35/36 (in situ hybridization)
|
|
|